Clinical Trial Update: Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating intracavernous injection of autologous mesenchymal stem cells for erectile dysfunction in patients with type 1 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Type 1 Diabetes Mellitus

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Erectile Dysfunction, Stem Cells | Phase 1 | Status: UNKNOWN